title: Monthly rifampicin, ofloxacin, and minocycline therapy for generalized and localized granuloma annulare.
abstract: BACKGROUND
  The localized form of granuloma annulare is usually self-limiting, resolving within 2 years. Generalized granuloma annulare, on the other hand, runs a protracted course, with spontaneous resolution being rare. It is also characterized by a later age of onset, an increased incidence of diabetes mellitus, poor response to therapy, and an increased prevalence of HLA Bw35.
  
  
  OBJECTIVE
  To assess the efficacy of monthly pulsed rifampicin, ofloxacin, and minocycline (ROM) therapy in the management of granuloma annulare.
  
  
  METHODS
  Six biopsy proven patients of granuloma annulare were included in the study, five of the generalized variety, and one localized. Three of these patients were resistant to standard modalities of treatment. All six patients were treated with pulses of once monthly ROM till complete resolution of all lesions. Results were analyzed in terms of complete resolution of lesions and side effects. Presence of comorbid conditions was noted.
  
  
  RESULTS
  All six patients were successfully treated with 4-8 pulses of monthly ROM. None of the patients reported any adverse effects.
  
  
  CONCLUSIONS
  Small sample size and the lack of a control group are limitations.
  
  
  CONCLUSIONS
  Treatment with pulses of once monthly ROM caused complete resolution of lesions in both localized and generalized granuloma annulare, even in cases recalcitrant to conventional therapy. There were no side effects in any of the patients. Larger trials are needed to substantiate the efficacy of monthly ROM in granuloma annulare.
authors.affiliation: Department of Dermatology, Army College of Medical Sciences, Base Hospital, Delhi Cantt, India.
authors.forename: Shilpa
authors.initials: S
authors.lastname: Garg
authors.forename: Sukriti
authors.initials: S
authors.lastname: Baveja
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D016460:Granuloma Annulare / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D008911:Minocycline / Q000008:administration & dosage*; D015242:Ofloxacin / Q000008:administration & dosage*; D011446:Prospective Studies; D012293:Rifampin / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D015242:Ofloxacin; D008911:Minocycline; D012293:Rifampin